| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in IONS over the last quarter tilts toward buying: insiders added a net 20,000 shares worth roughly $1.1M.
Classified under Biotechnology (Health Care sector), IONS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 242.8K | $12.46M | - | |
| Dir | 161.2K | - | - | |
| VP | 102.9K | $5.28M | - | |
| CFO | 82.7K | $6.05M | - | |
| VP | 60.1K | $3.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | Hayden Michael R58 | Director | Buy | 20,000 | $52.94 | $1,058,700.00 | +500.0% | - | - | |
| Jul 7, 2026 | Diaz Allene M. | Director | Sale+OE | 10,111 | $85.42 | $863,637.13 | -72.6% | - | - | |
| Jul 7, 2026 | Kordasiewicz Holly B. | EVP, Chief Development Officer | Sell | 362 | $84.30 | $30,516.60 | -1.6% | - | - | |
| Jul 7, 2026 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sell | 20,536 | $84.95 | $1,744,623.34 | -100% | - | - | |
| Jul 1, 2026 | Klein Joseph III60 | Director | Sale+OE | 11,518 | $79.04 | $910,416.46 | -51.1% | - | - | |
| Jun 26, 2026 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sell | 3,069 | $80.00 | $245,520.00 | -4.8% | - | - | |
| Jun 26, 2026 | Schneider Eugene62 | EVP, Chf Clinical Develop Ofcr | Sale+OE | 26,000 | $81.05 | $2,107,196.00 | -25.2% | - | - | |
| Jun 26, 2026 | Baroldi Joseph53 | EVP, Chief Business Officer | Sale+OE | 5,635 | $80.16 | $451,698.78 | -54.7% | - | - | |
| Jun 26, 2026 | Monia Brett P60 | Chief Executive Officer | Sale+OE | 85,637 | $79.70 | $6,825,523.71 | -25.9% | - | - | |
| Jun 25, 2026 | Swayze Eric63 | EVP Research | Sell | 10,602 | $79.18 | $839,491.80 | -32.8% | - | - |